Altered procollagen gene expression in mid-gestational mouse excisional wounds

Area of Science:

• Developmental biology
• Regenerative medicine
• Wound healing research

Background:

• Pathologic conditions often involve excessive tissue contraction and scarring.
• Murine models reveal scarless healing in mid-gestational wounds versus scar formation in late-gestational wounds.
• Procollagen gene expression variations are hypothesized to influence scarless and rapid wound closure.

Purpose of the Study:

• To investigate differences in procollagen gene expression between mid- and late-gestational fetal wounds.
• To correlate gene expression patterns with collagen deposition and healing outcomes.
• To understand molecular mechanisms underlying scarless fetal wound healing.

Main Methods:

• Excisional wounds were created in embryonic day 15 (E15) and 18 (E18) mouse fetuses.
• Procollagen types 1alpha1, 1alpha2, and 3 gene expression analyzed via real-time PCR.
• Collagen deposition assessed using trichrome staining at 32, 48, and 72 hours post-wounding.

Main Results:

• Procollagen 1alpha1 expression was lower in E15 wounds at 32 hours compared to controls.
• Procollagen types 1alpha2 and 3 expression increased in E15 groups versus E18 groups at 48 hours.
• E15 wounds showed normal collagen density by 72 hours, while E18 wounds had disorganized, increased collagen deposition.

Conclusions:

• Collagen gene expression patterns differ significantly between mid- and late-gestational fetal wounds.
• Altered procollagen expression in mid-gestation may favor scarless healing.
• Increased type 3 collagen and decreased type 1 collagen are associated with favorable scarless healing in fetuses.